Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment. (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgaa403

PubMed Identifier: 32617576

Publication URI: http://europepmc.org/abstract/MED/32617576

Type: Journal Article/Review

Volume: 106

Parent Publication: The Journal of clinical endocrinology and metabolism

Issue: 1

ISSN: 0021-972X